Henry Hagopian III
2022
In 2022, Henry Hagopian III earned a total compensation of $1.4M as Chief Financial Officer at Annovis Bio.
Compensation breakdown
| Non-Equity Incentive Plan | $131,250 |
|---|---|
| Option Awards | $1,156,680 |
| Salary | $129,327 |
| Total | $1,417,257 |
Hagopian received $1.2M in option awards, accounting for 82% of the total pay in 2022.
Hagopian also received $131.3K in non-equity incentive plan and $129.3K in salary.
Rankings
In 2022, Henry Hagopian III's compensation ranked 2,352nd out of 5,756 executives tracked by ExecPay. In other words, Hagopian earned more than 59.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,352 out of 5,756 | 59th |
Division Manufacturing | 1,281 out of 3,133 | 59th |
Major group Chemicals And Allied Products | 572 out of 1,419 | 60th |
Industry group Drugs | 527 out of 1,320 | 60th |
Industry Pharmaceutical Preparations | 381 out of 966 | 61st |
Source: SEC filing on April 28, 2023.
Hagopian's colleagues
We found two more compensation records of executives who worked with Henry Hagopian III at Annovis Bio in 2022.